Table 5.
Effect of vitamin D intake on hemoglobin levels
| Estimate, 95% CI, P(Week × treatment)a | ||
|---|---|---|
| FE vs FEMTb | FE vs PCGb | |
| Week 2 × treatment | < 0.00, [−0.43, 0.43], 0.989 | −0.43, [−0.87, 0.01], 0.053 |
| Week 4 × treatment | 0.52, [0.09, 0.95], 0.019* | −0.14, [−0.58, 0.29], 0.512 |
| Week 6 × treatment | 0.36, [−0.07, 0.79], 0.100 | −0.33, [−0.76, 0.10], 0.130 |
Bold values represent the significantly different (*P < 0.05, ** P < 0.01)
aThe crude model (analyzed in Table 2) was adjusted for vitamin D intake, and the effect of treatment on hemoglobin levels was estimated. The test statistics are marked as *P < 0.05
bPCG placebo control group; FE intervention group administered 6 mg iron alone once daily; FEMT intervention group administered 200 mg methionine, 400 mg threonine, and 6 mg iron once daily